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Depression, auditory-verbal hallucinations, and delusions in patients with 
schizophrenia: different patterns of association with prefrontal gray and white 
matter volume 
 
ABSTRACT 
Structural brain abnormalities, including decreased gray matter (GM) and white matter 
(WM) volume, have been observed in patients with schizophrenia. These decrements 
were found to be associated with positive and negative symptoms, but affective 
symptoms (depression and anxiety) were poorly explored. We hypothesized that 
abnormalities in GM and WM volume might also be related to affective symptoms. GM 
and WM volumes were calculated from high-resolution T1 structural images acquired 
from 24 patients with schizophrenia and 26 healthy controls, and the associations of 
positive, negative, and affective symptoms with the brain volumes that showed 
significant reduction in patients were investigated. Patients demonstrated GM volume 
reductions in the bilateral prefrontal cortex, and WM volume reductions in the right 
frontal and left corpus callosum. Prefrontal cortex volume was significantly and 
inversely associated with both auditory-verbal hallucinations and depression severity. 
WM volume alterations, in contrast, were related to alogia, anhedonia, and delusions.  
The combined impact of auditory-verbal hallucinations and depression on similar sub-
regions of the prefrontal cortex suggests that depression is involved in hearing voices. 
Further, this adverse impact of depression on prefrontal GM volume may underlie the 
impairment demonstrated by these patients in cognitive tasks that rely on executive 
processes. 
2 
 
Key words: prefrontal cortex, depressive symptoms, auditory-verbal hallucinations, 
delusions.  
 
1. Introduction 
Schizophrenia is a severe mental illness characterized by brain structural 
abnormalities. Previous meta-analyses and studies using voxel-based morphometry 
(VBM) have revealed reduction in Gray Matter (GM) and White Matter (WM) volume in 
this population.  In particular, large GM volume reduction was observed in the 
prefrontal cortex (Fornito et al., 2009; Haijma et al., 2013; Ohtani et al., 2014b) and 
temporal cortex (Fornito et al., 2009). These volume reductions have been related to 
various positive and negative symptoms of schizophrenia. 
 
1.1.   Auditory Verbal Hallucinations 
 Auditory Verbal Hallucinations (AVHs) have mostly been related to GM volume 
reduction in the superior temporal gyrus, involved in the processing of language 
(Modinos et al., 2013; O’Daly et al., 2007; Palaniyappan et al., 2012; Rajarethinam et al., 
2000; Sun et al., 2009). Associations were also observed with reductions in the medial 
frontal lobe (Kubera et al., 2014), the inferior frontal gyrus (García-Martí et al., 2008; 
Gaser et al., 2004; Modinos et al., 2013) and other brain areas including the inferior 
supramarginal gyrus (parietal lobe) (Gaser et al., 2004), the insula (Kubera et al., 2014) 
and the putamen (Van Tol et al., 2014). AVH have also been related to WM volume 
decrement, more particularly in the right internal capsule and inferior longitudinal 
fasciculus —the fiber tract that connects the temporal and occipital lobes (O’Daly et al., 
2007), the postcentral gyrus (Van Tol et al., 2014), the occipital lobe, the corpus 
callosum (Makris et al., 2010), and the superior longitudinal fasciculus, which connects 
the frontal, occipital and temporal lobes (Seok et al., 2007).  
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1.2. Delusions 
Delusions in patients with schizophrenia have been found to be associated with 
GM volume reduction in the temporal (Crespo-Facorro et al., 2004; Song et al., 2015). 
and frontal (Maruff et al., 2004; Song et al., 2015) lobes, as well as in the right parietal 
lobe (Maruff et al., 2004). They are also associated with WM volume reduction in the 
medial temporal lobe (Makris et al., 2010). Few studies, nonetheless, have explored the 
neural correlates of specific types of delusions, mostly delusions of control, also called 
Schneiderian or passivity delusions, which might share certain neural underpinnings 
with AVH because of their shared self-agency defect component (Poletti et al., 2017). 
 
1.3. Negative symptoms 
With regard to negative symptoms, they have been associated with 
GM volume decrement in medial frontal and orbitofrontal areas in patients with 
schizophrenia (see Kaladjian et al., 2015 for a review). An association of negative 
symptoms with WM abnormalities has also been reported. This includes WM 
abnormalities in the superior longitudinal fasciculus in patients with first-episode 
psychosis (Sun et al., 2015) and with schizophrenia (Chuang et al., 2014). Further, 
avolition and anhedonia in patients with schizophrenia have been related to WM 
reduction in the corpus callosum (Nakamura et al., 2012), left posterior medial 
orbitofrontal cortex, and left anterior cingulate cortex (Ohtani et al., 2014a). Another 
study found reduced WM volume in the cingulate region to be associated with alogia 
(Makris et al., 2010). 
 
1.4. Affective symptoms 
There is abundant evidence suggesting that affective conditions have significant 
associations with the severity, distress and content of psychotic experiences. Anxiety 
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and depression, as two specific affective conditions, may be prodromes for psychosis 
(Hartley et al., 2013). Although the effects of affective symptoms on GM and WM 
volumes have been studied in patients with depression (Ballmaier et al., 2004; Zhang et 
al., 2016) and  anxiety disorders (Jackowski et al., 2012), only one study, as far as we 
know, has examined the effect of depression on brain volume in schizophrenia. Results 
showed that depression severity was associated with lower GM orbitofrontal volume in 
female patients (Gur et al., 2000). 
Considering the high prevalence of depression and anxiety in patients with 
schizophrenia, it is possible that these symptoms have a significant role in the GM and 
WM volume reductions observed in this population. More specifically, depression is 
often observed in patients with auditory-verbal hallucinations and delusions and it is 
therefore important to tease apart the potential effects of depressive symptoms from 
those of positive symptoms. Further, given the overlap between depressive and negative 
symptoms, the extent to which the observed effects of negative symptoms on GM and 
WM abnormalities might have been influenced by the shared depressive component 
needs to be assessed. 
 
1.5. Aims of the study 
In this study we identified brain areas in which GM or WM volume reduction was 
observed in patients with schizophrenia, and we sought to determine the clinical 
symptoms that were involved in these volume reductions.  The targeted symptoms were 
AVH, Schneiderian and non-Schneiderian delusions, negative symptoms, and affective 
symptoms. 
 
2. Methods 
The involved institutions approved the study protocol in accordance with 
Declaration of Helsinki (World Medical Association, 2013) guidelines. All procedures 
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were approved by the Parc Sanitari Sant Joan de Déu ethics committee, and all 
participants provided written informed consent. All the rating scales were
 administrated by means of interview by an experienced clinical psychologist. 
 
2.1. Participants 
Twenty-seven healthy participants were recruited from the general population by  
means of announcements, although one participant was eventually excluded due to the 
poor quality of the MRI images. Inclusion criteria were age between 18 and 60 years and 
fluency in Spanish.  Exclusion criteria were neurological or mental illness, intellectual 
disability, head injury, alcohol or drug abuse in the previous six months, and current 
severe physical disease, as well as the standard exclusion criteria for MRI procedures: 
claustrophobia and metallic implants (fitted pacemaker and cochlear implants).  
Twenty-four patients with schizophrenia (American Psychological Association 
(APA), 2002) were recruited from the Parc Sanitari Sant Joan de Déu network of mental 
health services in Barcelona, Spain. All patients were receiving antipsychotic treatment. 
Inclusion criteria were the same as those for healthy participants with the additional 
criterion of being able to provide informed consent. Exclusion criteria were also the 
same except that the mental disease exclusion criterion only applied to organic mental 
disorders and dementia.   
 
2.2. Clinical rating scales 
Positive and negative symptoms were assessed in patients using the Spanish 
version of the Scale for the Assessment of Positive Symptoms (SAPS)(Andreasen, 2000) 
and the Scale for the Assessment of Negative Symptoms (SANS)(Andreasen, 1989; 
Peralta and Cuesta, 1999). With respect to positive symptoms, an AVHs score was 
computed by summing the scores obtained on the 2nd and 3rd items of the SAPS 
hallucination scale (‘voices commenting’ and ‘voices conversing’).  A Schneiderian 
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delusions (Schneider, 1959) (delusions of mind reading and of being controlled, thought 
broadcasting, thought insertion, thought withdrawal) score, consisting of the sum of the 
15th – 19th (5 items), and a ‘non-Schneiderian delusions’ score  consisting of the sum of 
the remaining delusion items (delusions of persecution, jealousy, guilt or sin, religious, 
reference, grandiose, and somatic) were also computed. Negative symptom scores were 
tallied for flat affect, alogia, avolition, and anhedonia. Depression was assessed using the 
Calgary Depression Scale, specifically designed to assess depression in schizophrenia and 
differentiate it from negative symptoms (Addington et al., 1992; Sarro et al., 2004).  
Anxiety was measured using the Hamilton Anxiety Rating Scale (Hamilton, 1959; Lobo et 
al., 2002). Clinical variables that did not follow normal distribution were normalized by 
square-root transformation. Chlorpromazine equivalence was calculated for 
antipsychotic drug doses according to Gardner (Gardner et al., 2010). 
 
2.3. MRI Data Acquisition 
MRI data were acquired using a General Electric 1.5 Tesla SignaHDe scanner at Parc 
Sanitari Sant Joan de Déu. High-resolution T1-weighted FSPGR structural images with 
the axial plane parallel to the AC-PC axis were acquired using the following parameters: 2 
mm slice thickness, TR = 12.24 ms, TE = 3.84 ms, FOV = 24 cm, acquisition matrix = 512 × 
512, flip angle = 20°, voxel size = 0.47 × 0.47 × 2.0 mm3 (individual voxel volume: 0.442 
mm3). 
 
2.3.1 Preprocessing of imaging data 
Preprocessing followed the default procedures used in the VBM8 toolbox 
 http://dbm.neuro.uni-jena.de/vbm8/VBM8-Manual.pdf, running within the Statistical 
Parametric Mapping software package version 8 
(SPM8;http://www.fil.ion.ucl.ac.uk/spm), using MATLAB (R2010b, The MathWorks, Inc., 
Natick, Massachusetts). We normalized T1 images to a template space provided by the 
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Montreal Neurological Institute (MNI) stereotactic space, which includes high-
dimensional DARTEL (Diffeomorphic Anatomic Registration Through Exponentiated Lie) 
algebra normalization (Ashburner, 2007). Subsequently, we segmented into GM, WM, and 
cerebrospinal fluid (CSF) and performed the non-linear modulation step (the modulation 
step multiplies the spatially normalized images by their relative volume before and after 
spatial normalization). The final GM and WM were extracted by segmenting the individual 
raw T1 images using standard GM, WM and CSF probability maps and then smoothed 
using an 8-mm full-width at half maximum Gaussian kernel. 
 
2.4 Statistical analysis  
2.4.1 Descriptive analysis  
Means with standard deviations are reported for continuous variables. Counts and 
percentages are reported for categorical variables. Differences by groups in continuous 
variables were explored with t-test or ANCOVA, whenever appropriate. Categorical 
analyses were done with the x2 test. Pearson correlation was used to explore the 
associations between the depression and negative scores (SANS total). All tests were 
performed with SPSS version 21 (IBM Corp. Released, 2012). 
 
2.4.2 Voxel-based morphometry analysis  
We performed a data-quality check to ensure sample homogeneity prior to the 
analyses with the VBM8 toolbox. This procedure was executed using the ‘check sample 
homogeneity’ function.  Following this, the raw volumes for GM, WM and CSF, and total 
intracranial volumes (the sum of GM, WM and CSF) of the segmented raw images were 
calculated. To identify regions with volume reduction in patients, we conducted a 
between-group comparison by means of a t-test, adding age and sex as covariates due to 
their potential confounding effect on this association (Kaufmann et al., 2001; Núñez et 
al., 2018). To further reduce the potential effects of tissue overlap occurring at tissue 
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border regions, we used, separately, the implicit GM and WM masks included in SPM8. 
We calculated GM and WM volume differences between groups separately using a 
cluster-defining voxel-level threshold (CDT) defined by p <0.001 together with a family-
wise-error (FWE) corrected cluster extent threshold p<0.05. A more restrictive CDT 
p<0.0001 and cluster level FWE-corrected p<0.05 were applied if the clusters generated 
by the more permissive CDT spanned several brain regions.  For both cases, individual 
patient tissue density scores were extracted from the volumes of interest (VOI) defined 
by the statistically significant clusters. Then, to better identify the individual brain 
structures within clusters encompassing several brain regions, a more restrictive voxel-
wise threshold p <0.0001, followed by cluster level FWE-corrected with p<0.05 were 
applied.  
 
2.4.3 Potential confounders 
 To identify potentially confounding factors in the associations with clinical 
symptoms, we conducted regression analyses on the GM and WM VOIs identified in the 
patient group.  The predictors were the socio-demographic measures (age, sex, education 
and verbal IQ), antipsychotic dosage, and illness duration. Regression analyses were also 
conducted in the healthy sample using solely the socio-demographic measures as 
predictors to determine whether potential associations were similarly observed in this 
group. 
 
2.4.4 Associations with clinical symptoms in the patient group  
 The associations between GM and WM permissive CDT (p < 0.001) and clinical 
symptoms were investigated by means of regression analyses. We first conducted a 
regression analysis using the four negative symptoms (flat affect, alogia, avolition and 
anhedonia) along with the confounding factors identified in the previous step. The 
backward method was used to eliminate step by step the factors which did not 
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contribute to the model. Subsequently, another regression analysis was performed with 
the affective (depression and anxiety) and positive (AVH, Schneiderian and non-
Schneiderian delusions) symptom scores entered as predictors along with the 
contributors identified in the previous step.  Again, the backward method was used to 
eliminate non-associated variables.  The final model resulting from this latter regression 
analysis was then used on each of the brain structures identified with a more restrictive 
cluster-defining threshold p <0.0001, so as to investigate the associations between the 
clinical symptoms of interest and more specific brain areas.  
 
3. Results 
Baseline demographics and clinical characteristics of patients and healthy 
controls are summarized in Table 1. Depression score was highly significantly correlated 
with SANS score (r= 0.69, p < 0.0001), which suggests an overlap between these two 
scales. 
------------------------------------------------------------------- 
Insert Table 1 
------------------------------------------------------------------- 
3.1. Total brain volume and identification of regions with significant deficit in patients 
There were significant GM volume differences, but not for WM, CFS and total 
intracranial volume between groups (see table A1 in supplementary materials). We 
observed decreased GM and WM volume and increased cerebrospinal fluid volume in 
schizophrenia patients compared with healthy controls.  
A comparison of patients with schizophrenia and healthy subjects, made using a 
permissive CDT p< 0.001 followed by an FWE-corrected p< 0.05, revealed reduced GM 
and WM volumes in the prefrontal cortex in patients. The following brain structures 
(identified with a more restrictive cluster-defining threshold p <0.0001) showed a GM 
reduction in patients: bilateral superior frontal gyrus, right medial superior frontal 
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gyrus and middle frontal gyrus, right medial orbitofrontal cortex and bilateral rectus 
gyrus while reductions in WM (identified with a more restrictive CDT p<0.0001) were in 
the tract adjacent to the right superior frontal gyrus and in the left body of the corpus 
callosum. In the case of GM, mean densities were obtained over a 274 voxel-sized cluster 
remaining after FWE correction of a restrictive CDT p <0.0001. In the case of WM, mean 
densities were obtained over a 553-voxel cluster remaining after FWE correction at the 
cluster level (see Table 2, Figure 1).  
 
------------------------------------------------------------------- 
Insert Table 2 
------------------------------------------------------------------- 
 
3.2. Associations between prefrontal GM and WM volume reduction and socio-demographic 
measures, antipsychotic dosage, and illness duration 
3.2.1 GM  
In the patient group, the model with the 6 predictors (R2= 0.69, F (6, 23) = 6.20, 
p<0.001) revealed  a significant negative contribution of age (β=-0.627, p= 0.015) and a 
trend level positive contribution of verbal IQ (β=0.369,  p=0.08) to the GM prefrontal VOI 
resulting from permissive CDT p < 0.001. Education level, illness duration and 
antipsychotic dosage were not significantly related to GM volume (p > 0.10). Sex was a 
significant predictor (β=0.489, p=0.015) and examination of the data showed that 
women had larger prefrontal volume than men (estimated marginal means: 0.46 vs. 
0.42). 
In the control group, the model with 4 predictors (R2=0.56, F (4, 25) = 6.73, 
p<0.001) similarly revealed a negative association with age, although only at a trend 
level of significance (β=-0.350, p=0.063).  Sex was again a significant predictor (β=0.366, 
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p=0.028) and, as was observed in patients, women had larger frontal volumes than men 
(estimated marginal means: 0.50 vs. 0.47). 
To determine whether women’s volume superiority was equivalent in both 
groups, we compared the prefrontal GM volume resulting from permissive CDT of 
patients and controls using a univariate general model with age, education level, and 
verbal IQ as covariates.  A strong effect of sex was revealed (F (1.43) = 13.9, p <0.001) 
without any interaction with group (F< 1, p=0.60).  
 
3.2.2 WM 
 No association between the WM prefrontal VOI resulting from permissive CDT 
and any of the four socio-demographic factors was observed in either group, and no 
association with antipsychotic dosage or illness duration was observed in the patient 
group. 
 
3.3 Associations of frontal GM and WM volume with clinical symptoms in patients 
3.3.1. GM 
Regression analysis on GM VOI, including the four negative symptom scores 
along with age, sex and verbal IQ, and using the backward method, resulted in a final 
model with a significant contribution of anhedonia (β =-0.30, p < 0.025) along with age, 
sex, and verbal IQ.  These four factors were entered into a subsequent regression 
analysis, along with the positive and affective symptoms.  The contribution of anhedonia 
was no longer observed.  The backward method resulted in a significant 5-factor model 
with significant contributions of age, sex, AVHs and depression, and a trend level 
contribution of non-Schneiderian delusions (see Table 3).  It should be noted that the 
‘Schneiderian delusion’ score made a near-zero contribution to the model and was the 
first factor to be eliminated by the backward method.  
12 
 
Regression analyses using this 5-factor model were then conducted on each of 
the GM VOIs resulting from a restrictive CDT.  Results are presented in Table 3. AVHs 
tended to be negatively associated with the right medial superior frontal and right 
orbitofrontal gyrus, while the association with the left superior frontal gyrus was near 
zero.  The depression score was inversely associated with the right medial superior 
frontal and right orbitofrontal gyrus, and, at a trend level, with the right middle frontal 
and superior frontal gyrus (Figure 2).  
 
------------------------------------------------------------------- 
Insert Table 3 
------------------------------------------------------------------- 
3.3.2. WM 
 The first regression analysis, including only the four negative symptoms, 
revealed significant contributions of anhedonia and alogia to the WM prefrontal VOI 
(resulting from the permissive CDT) in the final model. Anhedonia and alogia were then 
entered into a second regression analysis along with positive (AVH, Schneiderian 
delusions, non-Schneiderian delusions) and affective (depression, anxiety) symptom 
scores.  The AVHs score did not make any contribution to the WM VOI (β near zero) and 
it was the first factor to be eliminated by the backward method. The last model revealed 
significant contribution of anhedonia, alogia, and non-Schneiderian delusions.  When the 
Schneiderian delusion score was entered into this last model instead of the non-
Schneiderian score, it also made a trend significant contribution to WM, suggesting that 
both type of delusions were associated with WM reduction.  We therefore used a final 
model with anhedonia, alogia, and global delusion score (see Table 4). 
Regression analyses using this 3-factor model were then conducted on each of 
the specific clusters identified.  The global delusion score made a significant negative 
contribution to the right superior frontal WM cluster, again with contribution of both 
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Schneiderian (β = -0.338, p < 0.07) and non-Schneiderian (β = -0.362, p < 0.05) 
delusions.   
 
------------------------------------------------------------------- 
Insert Table 4 
------------------------------------------------------------------- 
 
 
4. Discussion 
Various studies of schizophrenia (Fornito et al., 2009; Y. Zhang et al., 2016) and 
individuals at high risk of psychosis (Gogtay et al., 2011) have revealed decrements in 
the frontal cortex relative to healthy controls. In line with these, we observed reduced 
GM volume in various areas of the prefrontal cortex in our patient sample. Further, WM 
volume reduction was observed in the tract adjacent to the right superior frontal gyrus 
and the body of the corpus callosum, in agreement with other studies (Collinson et al., 
2014; Knöchel et al., 2012; Nakamura et al., 2012; Ohtani et al., 2014a). These volume 
decrements in both GM and WM were found to be differentially associated with specific 
positive, affective, and negative symptoms. 
 
4.1. AVHs  
AVHs were significantly associated with decreased GM in the prefrontal cortex. 
In particular, they were associated, although only at trend level, with decreased GM in a 
brain area that encompasses the right medial superior frontal and medial orbitofrontal 
cortex.  Although research has mostly documented a relationship between severity of 
AVHs and GM reduction in the left superior temporal gyrus in schizophrenia patients 
(Modinos et al., 2013; O’Daly et al., 2007; Rajarethinam et al., 2000; Sun et al., 2009), this 
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type of hallucination has also been related to GM reduction in the right prefrontal gyrus 
in previous research (Gaser et al., 2004; Modinos et al., 2009; Zmigrod et al., 2016), in 
agreement with our data. This association with prefrontal cortex volume may underlie 
the link between AVHs and certain executive functions, namely working memory 
(Brébion et al., 2015; Daalman et al., 2011; Gisselgård et al., 2014),  set-shifting (Siddi et 
al., 2017; Waters et al., 2012), and semantic fluency (DeFreitas et al., 2009) observed in 
several studies.  
 
4.2. Delusions 
Delusions too have been found to be associated with reduced frontal GM volume 
in previous research (Maruff et al., 2004; Song et al., 2015). However, this association 
may partly result from overlap between AVH and a certain type of delusions, namely 
Schneiderian delusions. Indeed, both AVH and Schneiderian delusions are related to a 
lack of the sense of self-agency (Poletti et al., 2017), which might be subserved by the 
prefrontal cortex. In our data, non-Schneiderian delusions tended, on the contrary, to be 
associated with increased prefrontal GM volume. Their neural underlying mechanism, 
thus, seems to be entirely different from that of AVHs.  Further, both Schneiderian and, 
at a trend level, non-Schneiderian delusions were associated with decreased prefrontal 
WM, particularly in the right superior frontal gyrus. WM alterations in various neural 
regions including the frontal lobe may lead to deficits in social cognition (Wang and 
Olson, 2018), which might be a cognitive underpinning of various types of delusions 
(Park, 2018). Delusions have also been found to be associated with WM reduction in the 
medial temporal lobe in patients with schizophrenia (Makris et al., 2010). These findings 
may reflect involvement of both GM and WM in various types of delusions. 
 
4.3. Depression 
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Although depressive symptoms are highly prevalent in patients with 
schizophrenia, they are not commonly taken into account in neural studies in this 
population.  Our results suggest nonetheless that depression has a significant impact on 
GM volume reduction, which might have been overlooked in previous research and 
confounded by the effects of negative symptoms. Indeed, in our data, the contribution of 
anhedonia, which emerged in the first step of the regression analysis, was no longer 
significant when depressive symptoms were entered into the model.  Similarly, the 
effects of negative symptoms on GM reported in numerous studies might partly stem 
from overlap between negative and depressive symptoms.  
Our findings indicate that depression had a significant impact on GM reduction 
in the prefrontal cortex, more specifically in the right medial superior frontal, medial 
orbitofrontal, and superior frontal and middle frontal gyrus.  This observation is in 
agreement with that of Gur et al. (2000) who reported that lower GM orbitofrontal 
volume was associated with greater depression severity in schizophrenia, although this 
was only observed in women in their study.  
The orbitofrontal cortex is essential for the interaction between emotional 
valence and self-monitoring, as well as social behavior (Beer et al., 2006), and the 
detrimental effect of depression on this brain area might participate in the self-
monitoring disturbance that leads to AVHs (Waters et al., 2012). In addition, this impact 
of depression on GM prefrontal volume probably explains the adverse effects of 
depression on cognitive performance in this population. In particular, it was observed in 
several schizophrenia samples that depression severity affected memory efficiency 
(Brébion et al., 2013; Sanfilipo et al., 2002) and specifically impacted the deep/effortful 
processes of verbal encoding (Brébion et al., 2001, 2000; Lysaker et al., 2000; Möser et 
al., 2006), allegedly subserved by the prefrontal cortex. Thus, this neuroimaging study 
confirms, at the brain structural level, the previous observation that depression in these 
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patients is a crucial impairment factor in the memory tasks that rely upon executive 
processes. 
Thus, our findings evince a critical involvement of depression in the brain 
dysfunction of patients with schizophrenia, with potential consequences for the clinical 
and cognitive manifestations of the disease. It should be noted that the average level of 
depression in our patient sample was low.  More striking results might have emerged in 
a sample with more significant levels of depression.  
 
4.4. Negative symptoms 
When depression was taken into account, none of the negative symptoms we 
investigated was found to have any impact on GM volume reduction.  In contrast, 
negative symptoms appeared to be significantly related to WM abnormalities.  
Anhedonia and alogia presented significant and opposite associations with WM volume 
in the prefrontal cortex, more specifically in the tract adjacent to the right superior 
frontal gyrus. The right superior frontal gyrus is involved in motivational processes 
(Spielberg et al., 2008). Previous studies have reported WM abnormalities in the frontal 
lobe to be associated with the negative symptoms of schizophrenia (Chuang et al., 2014; 
Ohtani et al., 2014a). In our data, anhedonia was further associated with WM volume 
reduction in the left corpus callosum. In line with this,  WM alterations in the corpus 
callosum have been found to be associated with alogia (Makris et al., 2010), avolition 
(Nakamura et al., 2012) and anhedonia (Lee et al., 2014) in patients with schizophrenia.   
 Thus, negative and depressive symptoms appear to be subserved by distinct 
structural abnormalities. This neural distinction may reflect the phenomenological 
distinction between them: low mood, suicidal ideation, and pessimism have more 
specificity for depression, whereas alogia and blunted affect may have more specificity 
as negative symptoms (Krynicki et al., 2018).  
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4.5. Limitations 
The main limitation of this study is the small size of the patient sample.  Further, 
we did not control certain factors that might have had some influence on the results, 
such as handedness, and a possible family-related risk of mental illness in the healthy 
participants. 
 
5. Conclusions 
 Our findings reveal the important role of depression in GM prefrontal volume 
decrement in schizophrenia.  Depression appears to impact the same brain areas as 
AVHs, and it may therefore have a critical role in the formation of voices, which are one 
of the most common and distressing symptoms of the disease.  Further, depression 
emerged as a more significant factor of GM prefrontal volume reduction than negative 
symptoms.  The potential effects of depressive symptoms should be more routinely 
taken into account in this type of investigation in order to better understand the 
pathological mechanisms of schizophrenia. Depression in schizophrenia has detrimental 
consequences, such as high relapse rate, suicidal ideation, increased mortality, reduced 
social adjustment and poor quality of life (Krynicki et al., 2018). Longitudinal 
investigations reported that depression can predate first-episode psychosis, or acute 
relapses, which may indicate their causal influence or role in triggering distressing 
experiences (Hartley et al., 2013). Our findings indicate that the impact of depression in 
patients with schizophrenia can also been evinced at the cerebral level.  
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Table 1. Baseline characteristics of patients and healthy controls  
 Patients  
(N=24) 
Healthy Controls 
        (N=26) 
Test  and p-value 
Socio-demographic factors     
Females (n) 10      11 x2=0.004 df=1 NS 
Age (mean , (SD) 41.1 (9.7) 36.9 (9.1) t=1.59   df=49 NS 
Educational levela (mean , (SD) 4.7  (1.39) 5.9 (1.63) t= -2.81     df=49 p<0.007 
IQ b (mean)  100     104 t=2.25,  df=49 p=0.029 
Clinical factors      
Age of first hospitalization  
mean , (SD) 
27.92 (9.45)   
Illness duration (mean , (SD) 13.2  (9.9) ----  
Antipsychoticsc    
Typical n (%) 5    (11.36) ----  
Atypical n (%) 39 (88.63) ----  
Dose (mg/day) (mean , (SD) 1019.16 (619.28)   
Positive Symptoms  Mean SD Range  
SAPSd(Total) 15.12                                16.20 (0-51) ----  
Auditory-verbal hallucinations 2.29                                   3.72 (0-10) ----  
Delusions total 6.83  7.99                      (0-30) ----  
Schneiderian delusions 
(passivity) 
2.91 4.70                   (0-17) ----  
Non-Schneiderian delusions 3.91 4.67                  (0-20) ----  
Negative Symptoms  
SANSe (Total) 5.87 7.72                (0-27)   
Flat Affect  1.54  2.47                (0-9) ----  
Alogia 1.04  1.70                (0-5) ----  
Avolition 1.29  2.66                (0-10) ----  
Anhedonia 1.66  3.08                (0-12) ----  
Affective Symptoms 
Depressionf 3.83  4.96                (0-20) ----  
Anxietyg 7.91  5.77 (0-23) ----   
a Educational level based on the following classification: 1 = no formal education; 2 = uncompleted primary school; 3 = 
completed primary school; 4 = incompleted high school; 5 = completed high school; 6 = incompleted university education; 
7 = completed university education. 
b Assessed with TAP (Test de Acentuación de Palabras), Spanish equivalent of the National Adult Reading Test. 
c  Clinical dose in mg of chlorpromazine equivalents (mg/day)(Gardner et al., 2010) 
d Scale for the Assessment of Positive Symptoms. 
e Scale for the Assessment of Negative Symptoms.  
f Scores obtained by means of the Calgary Depression Scale. 
g Scores obtained by means of the Hamilton Anxiety Rating Scale. 
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Table 2. Areas with GM and WM density reduction in schizophrenic patients vs. 
healthy control subjects shown by VBM analysis.  
 
Abbreviations: L=left; R=right,  
 
All clusters satisfied FWE cluster-level correction at p<0.05 after a voxel-wise threshold  
p <0.001. 
MNI coordinates represent the peak voxel of each cluster where x, y, and z indicate the distance 
measured in millimeters from the anterior commissure in the sagittal, coronal, and axial planes, 
respectively
GM 
Coordinates  Label L/R t -value Cluster size 
X Y z      
9 70 13 Medial superior frontal gyrus+ 
Medial orbitofrontal gyrus 
R 5.72         830 
27 60 6 Middle frontal gyrus + 
Superior Frontal gyrus 
R 5.66         430 
2 45 -23 Gyrus rectus R/L 5.13        384 
-20 11 67 Superior frontal gyrus L 5.01        379 
                          WM    
  X Y Z     
18 54 15 Superior frontal gyrus R 5.42       459 
-14 -15 36 body of corpus callosum L 5.27       1004   
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                     Table 3. Pattern of relationship between GM and clinical symptoms. 
          AVHs Non-Schneid. 
delusions 
Depression Age Sex R2 F           df p 
Prefrontal cortex a -0.435** 0.261∞ -0.432** -0.616*** 0.317* 0.778 12.64 (5, 23) <0.0001 
Medial superior frontal g. Rb 
+Medial orbitofrontal g. R 
-0.288∞ 0.103 -0.317* -0.697*** 0.336* 0.741 10.31  (5, 23) <0.0001 
Superior frontal g.  and middle 
frontal g. R 
-0.310 0.293 -0.351∞ -0.122 0.395∞ 0.427 2.68 (5, 23) <0.06 
Rectus gyrus R/L -0.326 0.239 -0.254 -0.521* 0.036 0.391 2.31 (5, 23) <0.09 
Sup frontal L -0.053 0.149 -0.144 -0.412∞ -0.140 0.214 0.978 (5, 23) NS 
*** p <0.0001 **p≤0.01, *p≤ 0.05, ∞p<0.09. 
Note= A restrictive voxel-wise threshold p <0.0001 and a cluster extent threshold defined by a FWE corrected p<0.05 were applied for each region 
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    Table 4. Pattern of relationship between WM and clinical symptoms. 
  
 
 
 
 
 
*p <0.05      ** p <0.01      ***p <0.005 
Note= A restrictive voxel-wise threshold p <0.0001 and a cluster extent threshold defined  
by a FWE-corrected p < 0.05 were applied for each region 
 
 
 
 Anhedonia Alogia Delusions       R2 F df p 
Prefrontal cortexa -0.579***   0.415* -0.426* 0.462 5.72 (3, 23) 0.005 
Super frontal Rb -0.590***   0.418* -0.421* 0.467 5.84 (3, 23) 0.005 
Corpus callosum L -0.596**   0.234 -0.204 0.318 3.11 (3, 23) 0.05 
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Legend to figure 
Figure 1. Multiple axial slices are presented depicting those cerebral areas in which 
patients with schizophrenia show a significant (A) GM and (B) WM density reduction 
when compared to healthy controls. A restrictive voxel-level threshold defined by 
p<0.0001 and a cluster extent threshold defined by a FWE corrected p< 0.05 were used.  
Each slice is labeled according to the corresponding Z coordinate in the MNI anatomical 
space. 
 
Figure 2. GM volume abnormalities (red color scale) related to depression and 
controlled for AVHs, non-Schneiderian delusions, sex and age in the group with 
schizophrenia. Top Left:  GM volume reduction in the rectus gyrus was negatively 
associated with depression (R2= 0.391). Top right: GM volume reduction in the Medial 
superior frontal and orbitofrontal gyrus right negatively related to depression (R2= 
0.741).  A restrictive voxel-level threshold defined by p<0.0001 and a cluster extent 
threshold defined by a FWE corrected p< 0.05 was used.  Each slice is labeled according 
to the corresponding Z coordinate in the MNI anatomical space. 
 
 
 
 
 
 
 
 
 
 
 
